Literature DB >> 21718563

Bacterial conjunctivitis.

John Epling1.   

Abstract

INTRODUCTION: Most cases of conjunctivitis in adults are probably due to viral infection, but children are more likely to develop bacterial conjunctivitis than they are viral forms. The main bacterial pathogens are Haemophilus influenzae and Streptococcus pneumoniae in adults and children, and Moraxella catarrhalis in children. Contact lens wearers may be more likely to develop gram-negative infections. Bacterial keratitis occurs in up to 30 per 100,000 contact lens wearers. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of empirical treatment in adults and children with suspected bacterial conjunctivitis? What are the effects of treatment in adults and children with bacteriologically confirmed bacterial conjunctivitis? What are the effects of treatment in adults and children with clinically confirmed gonococcal conjunctivitis? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2009 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 40 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: ocular decongestants; oral antibiotics; parenteral antibiotics; saline; topical antibiotics; and warm compresses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21718563      PMCID: PMC2907624     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  53 in total

1.  Short term oral cefixime therapy for treatment of bacterial conjunctivitis.

Authors:  E R Wald; D Greenberg; A Hoberman
Journal:  Pediatr Infect Dis J       Date:  2001-11       Impact factor: 2.129

2.  Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1989-02       Impact factor: 5.790

3.  Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops.

Authors:  J Hvidberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-02

4.  A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

Authors:  D G Hwang; D J Schanzlin; M H Rotberg; G Foulks; M B Raizman
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

5.  Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms.

Authors:  Remco P Rietveld; Gerben ter Riet; Patrick J E Bindels; Jacobus H Sloos; Henk C P M van Weert
Journal:  BMJ       Date:  2004-06-16

6.  Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.

Authors:  W Bruce Jackson; Donald E Low; Dan Dattani; Paul F Whitsitt; Randall G Leeder; Rosemary MacDougall
Journal:  Can J Ophthalmol       Date:  2002-06       Impact factor: 1.882

7.  [A multicenter randomized study of fusidic acid ophthalmic gel and rifamycine eyedrops in acute conjunctivitis].

Authors:  J P Adenis; M Arrata; P Gastaud; S Limon; M Massin
Journal:  J Fr Ophtalmol       Date:  1989       Impact factor: 0.818

8.  Fusidic acid in infections of the external eye.

Authors:  O P van Bijsterveld; Y el Batawi; F S Sobhi; M W Nassar
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

9.  Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital.

Authors:  C P Fitch; P A Rapoza; S Owens; F Murillo-Lopez; R A Johnson; T C Quinn; J S Pepose; H R Taylor
Journal:  Ophthalmology       Date:  1989-08       Impact factor: 12.079

10.  The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group.

Authors:  I M Miller; J Wittreich; R Vogel; T J Cook
Journal:  Eur J Ophthalmol       Date:  1992 Apr-Jun       Impact factor: 1.922

View more
  2 in total

Review 1.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

Review 2.  Ocular redness - I: Etiology, pathogenesis, and assessment of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Sonia Anchouche; Ann Yung; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-16       Impact factor: 6.268

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.